Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea.
Department of Medicine, Korea University Graduate School, Seoul, South Korea; Cardiovascular Centre, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308 South Korea.
Arch Cardiovasc Dis. 2018 Mar;111(3):144-154. doi: 10.1016/j.acvd.2017.05.008. Epub 2017 Oct 10.
Long-term clinical outcome data according to severity of coronary artery spasm (CAS) as assessed by an intracoronary acetylcholine provocation test are limited in series of Asian patients.
To investigate 5-year clinical outcomes in patients with CAS according to CAS severity.
In total, 5873 consecutive patients with insignificant coronary artery disease (<70% fixed stenosis) who underwent an acetylcholine provocation test were enrolled and divided into four groups according to CAS severity during the acetylcholine provocation test: negative, borderline positive, moderately positive and severely positive. CAS severity was assessed by quantitative coronary angiography. We investigated 5-year clinical outcomes according to CAS severity.
Over a follow-up period of up to 5 years, before adjustment, the severely-positive CAS group showed a significantly higher incidence of major adverse cardiac events (MACE; composite of death, myocardial infarction and de novo revascularization) (hazard ratio [HR]: 1.834, 95% confidence interval [CI]: 1.047-3.211; P=0.033), total death (HR: 3.124, 95% CI: 1.047-9.322; P=0.041), myocardial infarction (HR: 3.190, 95% CI: 1.069-9.519; P=0.037) and recurrent angina (HR: 1.762, 95% CI: 1.363-2.278; P<0.001) compared with the negative group. However, after adjustment for baseline confounders, only the incidence of recurrent angina (HR: 1.323, 95% CI: 1.014-1.726; P=0.039) was significantly higher in the severely-positive CAS group compared with the negative group.
The severity of CAS in the positive group was not associated with an increased incidence of MACE after adjustment for covariates compared with the negative group, but the severely-positive CAS group was associated with a higher incidence of recurrent angina compared with the negative group.
根据乙酰胆碱激发试验评估的冠状动脉痉挛(CAS)严重程度,有关亚洲患者的长期临床结局数据在系列研究中较为有限。
根据 CAS 严重程度,研究 CAS 患者 5 年的临床结局。
共纳入 5873 例经乙酰胆碱激发试验检查诊断为无明显冠状动脉疾病(狭窄<70%)的连续患者,根据乙酰胆碱激发试验期间的 CAS 严重程度分为四组:阴性、边界阳性、中度阳性和重度阳性。CAS 严重程度采用定量冠状动脉造影评估。我们根据 CAS 严重程度调查了 5 年的临床结局。
在最长 5 年的随访期间,未经校正时,重度阳性 CAS 组主要不良心脏事件(MACE;死亡、心肌梗死和再血管化的复合终点)发生率显著更高(危险比 [HR]:1.834,95%置信区间 [CI]:1.047-3.211;P=0.033)、总死亡率(HR:3.124,95%CI:1.047-9.322;P=0.041)、心肌梗死(HR:3.190,95%CI:1.069-9.519;P=0.037)和复发性心绞痛(HR:1.762,95%CI:1.363-2.278;P<0.001)均显著高于阴性组。然而,在校正基线混杂因素后,仅重度阳性 CAS 组的复发性心绞痛发生率(HR:1.323,95%CI:1.014-1.726;P=0.039)显著高于阴性组。
与阴性组相比,校正协变量后阳性组的 CAS 严重程度与 MACE 发生率的增加无关,但与阴性组相比,重度阳性 CAS 组的复发性心绞痛发生率更高。